🚀 VC round data is live in beta, check it out!
Integrum Valuation Multiples
Discover revenue and EBITDA valuation multiples for Integrum and similar public comparables like European Medical Solutions, CS Diagnostics, Pulsenmore, Lifeward and more.
Integrum Overview
About Integrum
Integrum AB provides the system for bone-anchored prostheses that improves the lives of people with amputations. Its solutions include OPRA implant system, Neural prosthetics, Phantom limb pain treatment, and Prosthetic components. The company is also engaged in developing technology for mind-controlled prostheses and treatment for phantom limb pain.
Founded
1990
HQ
Employees
19
Website
Financials (LTM)
EV
$22M
Integrum Financials
Integrum reported last 12-month revenue of $9M and negative EBITDA of ($4M).
In the same LTM period, Integrum generated $7M in gross profit, ($4M) in EBITDA losses, and had net loss of ($3M).
Revenue (LTM)
Integrum P&L
In the most recent fiscal year, Integrum reported revenue of $10M and EBITDA of ($4M).
Integrum expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $9M | XXX | $10M | XXX | XXX | XXX |
| Gross Profit | $7M | XXX | $8M | XXX | XXX | XXX |
| Gross Margin | 76% | XXX | 83% | XXX | XXX | XXX |
| EBITDA | ($4M) | XXX | ($4M) | XXX | XXX | XXX |
| EBITDA Margin | (40%) | XXX | (38%) | XXX | XXX | XXX |
| EBIT Margin | (46%) | XXX | (44%) | XXX | XXX | XXX |
| Net Profit | ($3M) | XXX | ($3M) | XXX | XXX | XXX |
| Net Margin | (31%) | XXX | (29%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Integrum Stock Performance
Integrum has current market cap of $25M, and enterprise value of $22M.
Market Cap Evolution
Integrum's stock price is $0.93.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $22M | $25M | 0.3% | XXX | XXX | XXX | $-0.11 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialIntegrum Valuation Multiples
Integrum trades at 2.3x EV/Revenue multiple, and (5.8x) EV/EBITDA.
EV / Revenue (LTM)
Integrum Financial Valuation Multiples
As of April 20, 2026, Integrum has market cap of $25M and EV of $22M.
Equity research analysts estimate Integrum's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Integrum has a P/E ratio of (8.5x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $25M | XXX | $25M | XXX | XXX | XXX |
| EV (current) | $22M | XXX | $22M | XXX | XXX | XXX |
| EV/Revenue | 2.3x | XXX | 2.2x | XXX | XXX | XXX |
| EV/EBITDA | (5.8x) | XXX | (5.8x) | XXX | XXX | XXX |
| EV/EBIT | (5.0x) | XXX | (5.0x) | XXX | XXX | XXX |
| EV/Gross Profit | 3.0x | XXX | 2.7x | XXX | XXX | XXX |
| P/E | (8.5x) | XXX | (8.5x) | XXX | XXX | XXX |
| EV/FCF | (4.1x) | XXX | (4.1x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Integrum Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Integrum Margins & Growth Rates
Integrum's revenue in the last fiscal year declined by (5%).
Integrum's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.7M for the same period.
Integrum Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (5%) | XXX | XXX | XXX |
| EBITDA Margin | (40%) | XXX | (38%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 71% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.5M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.7M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 128% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Integrum Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Integrum | XXX | XXX | XXX | XXX | XXX | XXX |
| European Medical Solutions | XXX | XXX | XXX | XXX | XXX | XXX |
| CS Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Pulsenmore | XXX | XXX | XXX | XXX | XXX | XXX |
| Lifeward | XXX | XXX | XXX | XXX | XXX | XXX |
| Medclair | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Integrum M&A Activity
Integrum acquired XXX companies to date.
Last acquisition by Integrum was on XXXXXXXX, XXXXX. Integrum acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Integrum
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialIntegrum Investment Activity
Integrum invested in XXX companies to date.
Integrum made its latest investment on XXXXXXXX, XXXXX. Integrum invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Integrum
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Integrum
| When was Integrum founded? | Integrum was founded in 1990. |
| Where is Integrum headquartered? | Integrum is headquartered in Sweden. |
| How many employees does Integrum have? | As of today, Integrum has over 19 employees. |
| Is Integrum publicly listed? | Yes, Integrum is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Integrum? | Integrum trades under INTEG B ticker. |
| When did Integrum go public? | Integrum went public in 2017. |
| Who are competitors of Integrum? | Integrum main competitors are European Medical Solutions, CS Diagnostics, Pulsenmore, Lifeward. |
| What is the current market cap of Integrum? | Integrum's current market cap is $25M. |
| What is the current revenue of Integrum? | Integrum's last 12 months revenue is $9M. |
| What is the current EV/Revenue multiple of Integrum? | Current revenue multiple of Integrum is 2.3x. |
| Is Integrum profitable? | No, Integrum is not profitable. |
| What is the current EBITDA of Integrum? | Integrum has negative EBITDA and is not profitable. |
| What is Integrum's EBITDA margin? | Integrum's last 12 months EBITDA margin is (40%). |
| What is the current EV/EBITDA multiple of Integrum? | Current EBITDA multiple of Integrum is (5.8x). |
| What is the current FCF of Integrum? | Integrum's last 12 months FCF is ($5M). |
| What is Integrum's FCF margin? | Integrum's last 12 months FCF margin is (56%). |
| What is the current EV/FCF multiple of Integrum? | Current FCF multiple of Integrum is (4.1x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.